Areas of Expertise
  • Investment Banking
  • Biotech
  • Medical Devices
  • Cleantech
  • Internet
Contact Greg Curhan
Download vCard

Greg Curhan

Greg Curhan joined FLG in 2020 with over 35 years of operational, financial, capital markets and strategic advisory experience in various sectors including Investment Banking, Medical Device/Life Sciences, Internet, Clean Technology, and Investment/Wealth Management.  As CFO, Greg has managed Finance, Legal HR, and Investor Relations functions for Public and Private companies.  He has raised equity and debt capital for both private and public companies, completed a successful IPO, and executed M&A transactions both acquiring and divesting companies.  He has also served in CEO, President and Board of Director capacities. In July 2020, Greg was appointed to the Advisory Board at Specific Diagnostics as the company prepares to launch its Reveal rapid susceptibility testing system in Europe.

Greg founded and was President of an investment bank (Merriman Curhan Ford) growing it from pre-revenue startup to 250 employees, $90 million in revenue, profitability, and a Nasdaq listing within 7 years.  The investment bank raised over $5 billion dollars for corporate clients (both public and private) during that period in IPOs, Public offerings, PIPE financings and Private Placements, while also executing numerous successful M&A engagements in various Technology, Biotech, Medical Technology and Consumer sectors.

Prior to joining FLG, Greg was CFO and SVP Corporate Development of Providence Medical Technology, a venture backed medical device manufacturer whose purpose is to improve clinical outcomes for high-risk patients and prevent surgical failures of the cervical spine.  At Providence Greg raised multiple rounds of equity investment, identifying and bringing in a new lead investor in the company’s largest private round to date.  He arranged new debt financing facilities, increasing the size and extending the maturity twice in three years.  He introduced long term FP&A practices to support strategy formation and capital raising, including budgeting for a multi-year, randomized clinical trial.

Prior to that Greg was CEO of Clickworker USA, a US subsidiary of a venture backed German Crowdsourcing platform.  He was EVP and CFO of MCF Corporation, the parent company of Merriman Curhan Ford.  He was also CFO of WorldRes, a venture backed web-based hotel reservation booking engine.  In addition, Greg has worked for various investment banking firms including Merrill Lynch, Montgomery Securities, Volpe Brown Whelan and MLV.

Greg earned a BA degree in Economics (summa cum Laude and Phi Beta Kappa) from Dartmouth College.  He was an Adjunct Professor teaching Entrepreneurial Finance to MBA students at Dominican University and wrote and published a Novel Indomitable Spirit.

Sector Experience
  • Internet
  • Biopharma
  • Cleantech
  • Investment Banking
  • Medical Devices
Selected Engagements
Curevo Vaccine
Angion Biomedica Corp. Biopharma Public
Videos Featuring Greg Curhan
Pamela Rucker at Harvard University Interviews Greg Curhan
Preparing a Life Sciences Company for an IPO: Hosted by Moss Adams
Launching a Life Science IPO in the Midst of COVID: Angion Biomedica

View All Videos